Combining both peptides Some formulations include both AHK-Cu and GHK-Cu, attempting to capture benefits from each
Sometimes people use them as a stand-alone treatment, but some achieve the best results when peptides are part of an overall treatment plan
Dermal papilla cells, the master regulators at the base of each follicle, respond to AHK-Cu by increasing their numbers and extending their lifespan
MariTide has not been approved by the FDA yet and is currently in Phase 3 clinical trials
Improved Insulin Sensitivity and Glucose Metabolism When NAD levels rise and fat mass drops, cells become more responsive to insulin
Personalized Care Every dose is customized to support your individual energy, metabolism, and overall wellness goals